A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- Revolutionizing Cancer Care With Genomic Testingon March 28, 2024 at 8:00 am
In an interview with Targeted Oncology, David L. Bartlett, MD, discussed the utilization and growing importance of genomic testing in cancer care.
- Serum Detect Launches with Novel T-Cell Analysis Approach for Cancer Early Detection at AACRon March 28, 2024 at 6:27 am
The new company, led by a former executive from Foundation Medicine and Gritstone bio, is using advances in T-cell receptor repertoire analysis to reveal previously undetectable signals in standard ...
- Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meetingon March 28, 2024 at 6:01 am
Highlights include: Mini-symposium (Liquid Biopsy): Ultra-sensitive ctDNA detection predicts response to immune checkpoint inhibition in advanced melanoma patients Speaker: Dr. Christoffer Gebhardt ...
- Making a Hard Diagnosis a Lot Easier on Patientson March 27, 2024 at 4:46 pm
BALTIMORE, Md. (Ivanhoe, Newswire) – Malignant brain cancer is aggressive, and biopsies are invasive and painful. But now, some doctors have developed a new method of confirming a diagnosis – a liquid ...
- What Are Myeloproliferative Neoplasms?on March 26, 2024 at 12:00 pm
Myeloproliferative neoplasms are a group of blood cancers that can occur when your bone marrow cells start producing abnormal blood cells.
- Liquid Biopsy for CRC Screening May Not Be Ready for Prime Timeon March 26, 2024 at 10:22 am
Compared with no screening, each method -- blood-based testing, fecal immunochemical testing (FIT), multitargeted stool DNA test with FIT (sDNA-FIT), and colonoscopy -- reduced the number of CRC cases ...
- GTG Global Collaborations and Innovation Updateon March 26, 2024 at 5:19 am
GTG’s global academic connections are exemplified by the Company’s collaboration with several high-profile universities involving a range of translational research projects, all focused on delivering ...
- Cancer Diagnostics Market From Good to Great Harnessing Future Market Size for Epic Successon March 25, 2024 at 6:21 pm
Report Ocean published a new report on the Global Cancer Diagnostics Market. The study includes an in-depth analysis of regional trends and market growth in North America, Europe, Asia-Pacific, and ...
- Blood Test Breakthrough: How Priming Agents Are Transforming Cancer Detectionon March 23, 2024 at 1:04 pm
Researchers have created a breakthrough method to enhance cancer detection in blood tests by using priming agents to increase circulating tumor DNA levels, offering a promise for early diagnosis and ...
- Blood test reveals best lung cancer treatmenton March 21, 2024 at 5:00 pm
Test for patients in England checks if tumours can be treated with pills rather than chemotherapy.
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- King Charles Speaks About Friendship ‘in Times of Need’ in First Speech Since Kate Middleton’s Cancer Diagnosison March 28, 2024 at 12:51 pm
His Royal Highness had a pre-recorded message during a church service before Easter Sunday, where he spoke about trying to lead by example.
- Popular Twitch, YouTube gamer from Michigan, Ninja, gets cancer diagnosison March 28, 2024 at 12:49 pm
He’s one of the most well-known gamers around and has been for many years with tens of millions of followers on multiple platforms. Michigan native, Ninja, says he has been diagnosed with skin cancer.
- Diagnosed with cancer in their 20s and 30s, these women turned to TikTok: 'It makes you feel less alone'on March 28, 2024 at 12:22 pm
Hi. My name is Jenna Lyons. I am a 36-year-old mom of three boys — 11, 9 and 5 — and I have Stage IV metastatic breast cancer. What you might need to know about that is, as of now, metastatic breast ...
- Nicole Eggert reveals what not to say to cancer patients amid breast cancer diagnosison March 28, 2024 at 11:44 am
Eggert admitted that prior to her diagnosis she never performed self-examinations to check her breasts for any abnormalities and only went off doctor visits, mammograms, and ultrasounds. She added ...
- How do you explain a cancer diagnosis to children?on March 28, 2024 at 10:59 am
There's nothing trivial about cancer - the very word is scary, and of course the condition can have dramatic effects - on the patient and those around them. And it can be specially hard to deal with ...
- Chelsea Paxton Hamel, co-host on Woody and Wilcox, reveals breast cancer diagnosison March 28, 2024 at 10:48 am
The cancer was detected early during a routine mammogram and her prognosis looks good, Paxton Hamel revealed Thursday morning.
- King Charles praises 'kindness' and friendship 'in times of need' ahead of his first public appearance since his cancer diagnosison March 28, 2024 at 9:18 am
King Charles III stepped back from public engagements after his cancer diagnosis, but he's set to make an appearance at an Easter Sunday service.
- A shocking cancer diagnosis — and an excellent patient outcome at Bon Secourson March 28, 2024 at 9:18 am
Content by Bon Secours. At Bon Secours, medical teams work together to provide the best possible care for cancer patients.
- Hear King Charles' first public remarks since Kate's cancer diagnosison March 28, 2024 at 8:28 am
King Charles III gave public remarks for Maundy, addressing the importance of acts of friendship, following his and Catherine, Princess of Wales' cancer diagnoses.
- Twitch streamer Tyler 'Ninja' Blevins reveals skin cancer diagnosis, encourages skin checkupson March 28, 2024 at 6:39 am
Tyler "Ninja" Blevins, a famous Twitch streamer, revealed his dermatologist discovered melanoma during a routine checkup.
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]